Formulary- Reporting guidelines
                                        Conditions d'achèvement
                                        
                                        
                                            
                                    
                            301.6 Ko · PDF
Cliquer le lien M4 Canada vigilance and voluntary adverse reaction reporting guidelines Aug 2015.pdf pour afficher le fichier.